The use of infliximab therapeutic drug monitoring in virtual biologics clinic for inflammatory bowel disease (IBD) leads to clinically durable results

被引:0
|
作者
Sagar, R. [1 ]
Lenti, M. [1 ]
Clark, T. [1 ]
Rafferty, H. [1 ]
Gracie, D. [1 ]
Ford, A. [1 ]
O'Connor, A. [1 ]
Hamlin, J. [1 ]
Ahmad, T. [2 ]
Selinger, C. [1 ]
机构
[1] St James Univ Hosp, Gastroenterol, Leeds, W Yorkshire, England
[2] Royal Devon & Exeter Fdn Trust, Gastroenterol, Exeter, Devon, England
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P737
引用
收藏
页码:S484 / S485
页数:3
相关论文
共 50 条
  • [41] Biologics for inflammatory bowel disease: Drug approval and monitoring in the United States
    Tremaine, William J.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (04) : 735 - +
  • [42] Therapeutic drug monitoring of biologics in Inflammatory Bowel Disease: Nordic survey on implementation and barriers in clinical practice
    Bjorlykke, K.
    Jahnsen, J.
    Brynskov, J.
    Molander, P.
    Eberhardson, M.
    Davidsdottir, L. G.
    Sipponen, T.
    Hjortswang, H.
    Langholz, E.
    Jorgensen, K. K.
    Steenholdt, C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I441 - I441
  • [43] A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease
    Cheifetz, Adam S.
    Abreu, Maria T.
    Afif, Waqqas
    Cross, Raymond K.
    Dubinsky, Marla C.
    Loftus, Edward V., Jr.
    Osterman, Mark T.
    Saroufim, Ariana
    Siegel, Corey A.
    Yarur, Andres J.
    Melmed, Gil Y.
    Papamichael, Konstantinos
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (10): : 2014 - 2025
  • [44] THERAPEUTIC DRUG MONITORING OF BIOLOGICS IN INFLAMMATORY BOWEL DISEASE: NORDIC SURVEY ON IMPLEMENTATION AND BARRIERS IN CLINICAL PRACTICE
    Bjorlykke, Kristin H.
    Jahnsen, Jorgen
    Brynskov, Jorn
    Molander, Pauliina
    Eberhardson, Michael
    Davidsdottir, Loa G.
    Sipponen, Taina
    Hjortswang, Henrik
    Langholz, Ebbe
    Jorgensen, Kristin K.
    Steenholdt, Casper
    GASTROENTEROLOGY, 2022, 162 (07) : S506 - S506
  • [45] Therapeutic drug monitoring of biologics in Inflammatory Bowel Disease: Nordic survey on implementation and barriers in clinical practice
    Bjorlykke, K.
    Jahnsen, J.
    Brynskov, J.
    Molander, P.
    Eberhardson, M.
    Davidsdottir, L. G.
    Sipponen, T.
    Hjortswang, H.
    Langholz, E.
    Jorgensen, K. K.
    Steenholdt, C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I441 - I441
  • [46] Therapeutic drug monitoring in patients with inflammatory bowel disease
    Andres J Yarur
    Maria T Abreu
    Amar R Deshpande
    David H Kerman
    Daniel A Sussman
    World Journal of Gastroenterology, 2014, (13) : 3475 - 3484
  • [47] Ustekinumab Therapeutic Drug Monitoring in Inflammatory Bowel Disease
    Saleh, Adam A.
    Stading, Rachel
    Miroballi, Natalia
    Glassner, Kerri
    Abraham, Bincy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S636 - S637
  • [48] Therapeutic drug monitoring in inflammatory bowel disease treatments
    Wang, Meng-Yao
    Zhao, Jing-Wen
    Zheng, Chang-Qing
    Sang, Li-Xuan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (15) : 1604 - 1607
  • [49] Therapeutic drug monitoring in patients with inflammatory bowel disease
    Yarur, Andres J.
    Abreu, Maria T.
    Deshpande, Amar R.
    Kerman, David H.
    Sussman, Daniel A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (13) : 3475 - 3484
  • [50] Therapeutic drug monitoring in inflammatory bowel disease treatments
    Meng-Yao Wang
    Jing-Wen Zhao
    Chang-Qing Zheng
    Li-Xuan Sang
    World Journal of Gastroenterology, 2022, (15) : 1604 - 1607